Annual Retained Earnings
-$129.34 M
+$65.63 M+33.66%
December 1, 2024
Summary
- As of March 5, 2025, TRDA annual retained earnings is -$129.34 million, with the most recent change of +$65.63 million (+33.66%) on December 1, 2024.
- During the last 3 years, TRDA annual retained earnings has fallen by -$35.67 million (-38.09%).
- TRDA annual retained earnings is now -709.01% below its all-time high of -$15.99 million, reached on December 31, 2019.
Performance
TRDA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$129.34 M
+$1.13 M+0.87%
December 1, 2024
Summary
- As of March 5, 2025, TRDA quarterly retained earnings is -$129.34 million, with the most recent change of +$1.13 million (+0.87%) on December 1, 2024.
- Over the past year, TRDA quarterly retained earnings has stayed the same.
- TRDA quarterly retained earnings is now -204.26% below its all-time high of -$42.51 million, reached on December 31, 2020.
Performance
TRDA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TRDA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.7% | 0.0% |
| 3 y3 years | -38.1% | +31.3% |
| 5 y5 years | -709.0% | +31.3% |
TRDA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.1% | +33.7% | -38.1% | +41.4% |
| 5 y | 5-year | -709.0% | +33.7% | -204.3% | +41.4% |
| alltime | all time | -709.0% | +33.7% | -204.3% | +41.4% |
Entrada Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$129.34 M(-33.7%) | -$129.34 M(-0.9%) |
| Sep 2024 | - | -$130.47 M(+12.1%) |
| Jun 2024 | - | -$116.44 M(-32.1%) |
| Mar 2024 | - | -$171.47 M(-12.1%) |
| Dec 2023 | -$194.97 M(+3.6%) | -$194.97 M(+5.1%) |
| Sep 2023 | - | -$185.43 M(-16.1%) |
| Jun 2023 | - | -$220.89 M(+13.3%) |
| Mar 2023 | - | -$194.96 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$188.28 M(+101.0%) | -$188.28 M(+15.0%) |
| Sep 2022 | - | -$163.66 M(+18.1%) |
| Jun 2022 | - | -$138.52 M(+20.1%) |
| Mar 2022 | - | -$115.34 M(+23.1%) |
| Dec 2021 | -$93.67 M(+120.3%) | -$93.67 M(+24.5%) |
| Sep 2021 | - | -$75.22 M(+23.7%) |
| Jun 2021 | - | -$60.79 M(+43.0%) |
| Dec 2020 | -$42.51 M(+165.9%) | -$42.51 M |
| Dec 2019 | -$15.99 M | - |
FAQ
- What is Entrada Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics annual retained earnings year-on-year change?
- What is Entrada Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly retained earnings year-on-year change?
What is Entrada Therapeutics annual retained earnings?
The current annual retained earnings of TRDA is -$129.34 M
What is the all time high annual retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high annual retained earnings is -$15.99 M
What is Entrada Therapeutics annual retained earnings year-on-year change?
Over the past year, TRDA annual retained earnings has changed by +$65.63 M (+33.66%)
What is Entrada Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TRDA is -$129.34 M
What is the all time high quarterly retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly retained earnings is -$42.51 M
What is Entrada Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TRDA quarterly retained earnings has changed by $0.00 (0.00%)